Devlin Macgregor Pharmaceuticals Announces New 2021 Product Line
Posted March 9, 2021 by devlinmacgregor
Devlin Macgregor announced general availability of three new products on Monday March 8th 2021
Feature News
* Provasic: The newest generation of blood lipid inhibiting therapeutics, featuring patented Advanced Molecular Delivery System (AMDS), offering near 100% efficacy with absolutely no side effects.
*Narcogesic: Unique, rectally administered two-part epoxy based, pain management system featuring tamper-proof design, that allows for patient self dosing and administration
* Solarestti: The only topical titration proven to block all currently licensed, single and dual-dose mRNA based SARS-Cov-2 (COVID-19) vaccines. For use in adults and children 3 and older only.
https://devlinmacgregor.com
-- END ---
| Contact Email | [email protected] |
| Issued By | Charles Nichols |
| Phone | 555-437-6600 |
| Business Address | 1000 Wunarmman-Kimble Business Park, Suite 5150 |
| Country | United States |
| Categories | Health |
| Tags | alec lentz , charles nichols , devlin macgregor , fredrick sykes , narcogesic , provasic , solarestti |
| Last Updated | March 9, 2021 |